Dolby Laboratories, Inc.
DLB- Exchange
- NYSE
- Industry
- Patent Owners & Lessors
- SEC CIK
- 0001308547
In the last 90 days, Dolby Laboratories, Inc. insiders filed 0 open-market purchases and 7 sales; 392 institutions reported holding it in 13F filings for Q2 2026, worth $3.26B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.71M in total
- 7
- 13F holdersQ2 2026, −22 vs. previous quarter
- 392
- 13F valueReported value at the end of Q2 2026
- $3.26B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding DLB, Q2 2026
No superinvestor reported holding DLB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Dolby Laboratories, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 (view filing)7:33 PM ET | Sep 1 | 2 days | Couling John DSVP, Entertainment | SSaleClass A Common Stock | −7.67K | $61.05 | −$468.0K | −6.1%118.7K after | 10b5-1 |
| Aug 27, 2026 (view filing)8:15 PM ET | Aug 25 | 2 days | Nicholson RyanVP, CAO and Corp. Controller | SSaleClass A Common Stock | −1.18K | $65.28 | −$77.2K | −3.3%34.5K after | |
| Aug 18, 2026 (view filing)5:14 PM ET | Aug 14 | 4 days | Revankar ShriramSVP, Advanced Technology Group | SSaleClass A Common Stock | −3.00K | $62.71 | −$188.1K | −3.9%73.3K after | 10b5-1 |
| Aug 12, 2026 (view filing)4:30 PM ET | Aug 10 | 2 days | Nicholson RyanVP, CAO and Corp. Controller | SSaleClass A Common Stock | −1.35K | $62.04 | −$83.6K | −3.6%35.6K after | |
| Aug 6, 2026 (view filing)5:28 PM ET | Aug 4 | 2 days | Nicholson RyanVP, CAO and Corp. Controller | SSaleClass A Common Stock | −357 | $60.63 | −$21.6K | −1.0%37.0K after | |
| Aug 5, 2026 (view filing)5:11 PM ET | Aug 3 | 2 days | Couling John DSVP, Entertainment | SSaleClass A Common Stock | −7.67K | $60.00 | −$460.0K | −6.1%118.7K after | 2 lots10b5-1 |
| Jul 6, 2026 (view filing)5:39 PM ET | Jul 1 | 5 days | Couling John DSVP, Entertainment | SSaleClass A Common Stock | −7.67K | $53.20 | −$407.9K | −6.1%118.7K after | 10b5-1 |
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Couling John DSVP, Entertainment | SSaleClass A Common Stock | −7.67K | $55.63 | −$426.4K | −6.1%118.7K after | 2 lots10b5-1 |
| May 27, 2026 (view filing) | May 22 | 5 days | Pendleton ToddSVP, Chief Marketing Officer | SSaleClass A Common Stock | −11.9K | $54.55 | −$647.8K | −22.3%41.5K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Revankar ShriramSVP, Advanced Technology Group | SSaleClass A Common Stock | −3.00K | $54.90 | −$164.7K | −3.6%80.6K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Dolby Laboratories, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,676,885 | $351.1M | 0.01% | +138,549+2.1% | Added |
| Vanguard Portfolio Management LLC | 4,950,702 | $260.3M | 0.01% | −20,122−0.4% | Reduced |
| Bank of New York Mellon Corp | 4,817,216 | $253.3M | 0.04% | +317,396+7.1% | Added |
| Morgan Stanley | 4,601,750 | $242.0M | 0.01% | −540,418−10.5% | Reduced |
| Vanguard Capital Management LLC | 2,721,876 | $143.1M | 0.00% | −4,499−0.2% | Reduced |
| First Trust Advisors LP | 2,705,504 | $142.3M | 0.08% | +450,571+20.0% | Added |
| State Street Corp | 2,317,402 | $121.8M | 0.00% | +26,823+1.2% | Added |
| Acadian Asset Management LLC | 1,897,597 | $99.7M | 0.12% | +326,223+20.8% | Added |
| Geode Capital Management, LLC | 1,842,203 | $96.9M | 0.01% | +77,094+4.4% | Added |
| FMR LLC | 1,585,579 | $83.4M | 0.00% | +573,059+56.6% | Added |